β2-Microglobulin modified with advanced glycation end-products induces monocyte chemotaxis in vivo [6]

Nephrology Dialysis Transplantation

Volumn 11, Issue 6, 1996, Pages 1189-1191

  Cai, Z ^a   Miyata, T ^a   Horie, K ^a   Iida, Y ^a   Maeda, K ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; BETA 2 MICROGLOBULIN; ENDOTOXIN; ADVANCED GLYCATION END PRODUCT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CHEMOTAXIS; GLYCATION; HEMODIALYSIS; HUMAN; KIDNEY AMYLOIDOSIS; LETTER; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; RAT; ANIMAL; DRUG EFFECT; NEUTROPHIL CHEMOTAXIS; WISTAR RAT;

ANIMALS; BETA 2-MICROGLOBULIN; CHEMOTAXIS, LEUKOCYTE; GLYCOSYLATION END PRODUCTS, ADVANCED; MONOCYTES; RATS; RATS, WISTAR;

EID: 0029666490     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027493     Document Type: Letter

References (0)